Budget Impact Analysis of Certolizumab Pegol in the Management of Patients With Moderate-To-Severe Active Rheumatoid Arthritis in Greece
Abstract
Authors
C. Tzanetakos N. Maniadakis G. Kourlaba A. Tzioufas A. Goules T. Theodoratou P. Christou